Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Newer Targets
Palleon Pharmaceuticals to Present Preclinical Data on EAGLE-Her2 and Anti-Siglec-9 Antibody…
Newer Targets
Codiak Presents First Preclinical Data for exoASO, Engineered Exosomes Designed to…
Newer Targets
Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Approval
AstraZeneca’s Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
Phase III
First China-manufactured Trastuzumab Biosimilar HLX02 Global Phase III Trial Met Primary…
Phase II
Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study…
Approval
BRUKINSA (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
AbbVie and Harpoon Expand Partnership with $510 Million Licensing Deal
Acquisitions
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
Deals
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics
Commercial
Eli Lilly to Add 100 Employees Following $400 Million Manufacturing Investment
Home
Clinical
Phase I
Phase I
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase I
CStone announces first patient dosed in the Phase I bridging registrational study of ivosidenib
Biospace News
-
November 20, 2019
Phase I
Sensei Biotherapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of SNS-301 in Patients with ASPH-Positive Head and Neck Cancer
Phase I
Boston Biomedical, Inc. Highlights Phase 1 Data Evaluating Investigational WT1 Cancer Peptide Vaccine DSP-7888 (ombipepimut-S*) in Patients with Advanced Malignancies at SITC 2019
Phase I
Mustang Bio Announces Dosing of First Participant in Phase 1 Clinical Trial of MB-108 (Oncolytic Virus C134) to Treat GlioblastomaFirst dose occurred in trial...
Phase I
Asana BioSciences to Present Phase 1 Clinical Safety and Efficacy Data of Oral, Once-Weekly, ASN007, a Novel ERK 1/2 Inhibitor, at the AACR-NCI-EORTC Molecular...
Phase I
PBL gains approval to advance next generation anthrax vaccine to Phase...
Biospace News
-
October 22, 2019
0
Phase I
Principia Announces Positive Preliminary Data of PRN1008 for Immune Thrombocytopenia in...
Biospace News
-
October 15, 2019
0
Phase I
Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator...
Biospace News
-
October 11, 2019
0
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial...
Firstwordpharma News
-
July 18, 2019
0
Phase I
Ascentage Pharma announces first patient dosed in Phase I clinical trial...
Biospace News
-
July 15, 2019
0
1
2
3
...
19
Page 1 of 19
- Advertisement -
MOST POPULAR
Polyphor Shares Plunge After it Halts Enrollment in Two Pneumonia Trials...
May 13, 2019
Regeneron Discloses Two Deaths from its Bispecific Antibody RGN1979
May 8, 2019
Fast Company Selects Biotech Companies as Part of Its 2019 List...
February 20, 2019
Aerie’s Rocklatan approved by FDA for reducing intraocular pressure in patients...
March 13, 2019
Load more
HOT NEWS
Commercial
Alexion to Report First Quarter Results on Thursday, April 25, 2019
Deals
Liquidia and GSK Restructure Collaboration Agreement
Immuno-inflammation
Certolizumab Offers 2-Year Durable Response in Treating Plaque Psoriasis: Presented at...
Commercial
Expansion Projects Provide New Job Openings for Biotech Companies
